InterCure Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
INCR Nasdaq 2830 www.intercure.co

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for InterCure Ltd.

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds - Jun 22nd, 2026 6:50 am
InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition - Jun 15th, 2026 7:25 am
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow - Apr 30th, 2026 4:05 pm
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - Feb 19th, 2026 5:00 am
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million - Feb 19th, 2026 5:00 am
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation - Nov 3rd, 2025 6:30 am
Middle Eastern Penny Stocks With Market Caps Over US$1M - Sep 29th, 2025 3:04 am
Sector Update: Health Care Stocks Mixed Late Afternoon - Sep 19th, 2025 2:02 pm
InterCure Enters Premium US Cannabis Market With ISHI Deal - Sep 19th, 2025 8:06 am
InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands - Sep 19th, 2025 6:48 am